Intracellular distribution of differentially phosphorylated dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A)

Journal of Neuroscience Research

Volumn 92, Issue 2, 2014, Pages 162-173

  Kaczmarski, Wojciech ^a   Barua, Madhabi ^a   Mazur Kolecka, Bozena ^a   Frackowiak, Janusz ^a   Dowjat, Wieslaw ^a   Mehta, Pankaj ^a   Bolton, David ^a   Hwang, Yu Wen ^a   Rabe, Ausma ^a   Albertini, Giorgio ^b   Wegiel, Jerzy ^a  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

^b Instituto di Ricovero e Cura a Carattere Scientifico   (Italy)

Author keywords

Brain; Cytoskeleton; DYRK1A; Nucleus; Phosphorylation

Indexed keywords

DUAL SPECIFICITY TYROSINE PHOSPHORYLATION REGULATED KINASE 1A PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL TISSUE; ARTICLE; BRAIN HOMOGENATE; CELL FRACTIONATION; CELLULAR DISTRIBUTION; CHROMOSOME 21; CONTROLLED STUDY; CYTOSKELETON; CYTOSOL; DOWN SYNDROME; ENZYME PHOSPHORYLATION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; IMMUNOPRECIPITATION; ISOELECTRIC POINT; MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; TWO DIMENSIONAL GEL ELECTROPHORESIS;

BRAIN; CYTOSKELETON; DYRK1A; NUCLEUS; PHOSPHORYLATION;

ADULT; AGED; ANIMALS; BLOTTING, WESTERN; CELL NUCLEUS; CYTOPLASM; CYTOSKELETON; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FRONTAL LOBE; HUMANS; IMMUNOPRECIPITATION; MICE; MIDDLE AGED; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES;

EID: 84890018969     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.23279     Document Type: Article

References (52)

1. Adayev T, Chen-Hwang MC, Murakami N, Wegiel J, Hwang YW. 2006. Kinetic properties of a MNB/DYRK1A mutant suitable for the elucidation of biochemical pathways. Biochemistry 45:12011-12019.
2. Adayev T, Chen-Hwang MC, Murakami N, Lee E, Bolton DC, Hwang YW. 2007. Dual-specificity tyrosine phosphorylation-regulated kinase 1A does not require tyrosine phosphorylation for activity in vitro. Biochemistry 46:7614-7624.
3. Alvarez M, Estivill X, de la Luna S. 2003. DYRK1A accumulates in splicing speckles through a novel targeting signal and induces speckles disassembly. J Cell Sci 116:3099-3107.
4. Alvarez M, Altafaj X, Aranda S, de la Luna S. 2007. Dyrk1A autophosphorylation on serine residue 520 modulates its kinase activity via 14-3-3 binding. Mol Biol Cell 18:1167-1178.
5. Aranda S, Alvarez M, Turró S, Laguna A, de la Luna S. 2008. Sprouty2-mediated inhibition of fibroblast growth factor signaling is modulated by the protein kinase DYRK1A. Mol Cell Biol 28:5899-5911.
6. Arron JR, Winslow MM, Polleri A, Chang C-P, Wu H, Gao X, Neilson JR, Chen L, Heit JJ, Kim SK, Yamasaki N, Miyakawa T, Francke U, Graef IA, Crabtree GR. 2006. NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21. Nature 441:595-600.
7. Becker W, Joost HG. 1999. Structural and functional characteristics of Dyrk, a novel subfamily of protein kinases with dual specificity. Prog Nucleic Acid Res Mol Biol 62:1-17.
8. Becker W, Weber Y, Wetzel K, Eimbter K, Tejedor FJ, Joost HG. 1998. Sequence characteristics, subcellular localization, and substrate specificity of DYRK-related kinases, a novel family of dual specificity protein kinases. J Biol Chem 273:25893-25902.
9. Blom N, Gammeltoft S, Brunak S. 1999. Sequence and structure-based prediction of eukaryotic protein phosphorylation sites. J Mol Biol 294:1351-1362.
10. Canzonetta C, Mulligan C, Deutsch S, Ruf S, O'Doherty A, Lyle R, Borel C, Lin-Marq N, Delom F, Groet J, Schnappauf F, De Vita S, Averill S, Priestley JV, Martin JE, Shipley J, Denyer G, Epstein CJ, Fillat C, Estivill X, Tybulewicz VLJ, Fisher EMC, Antonarakis SE, Nizetic D. 2008. DYRK1A-dosage imbalance perturbs NRSF/REST levels, deregulating pluripotency and embryonic stem cell fate in Down syndrome. Am J Hum Genet 83:388-400.
11. Chan TO, Zhang J, Rodeck U, Pascal JM, Armen RS, Spring M, Dumitru CD, Myers V, Li X, Cheung JY, Feldman AM. 2011. Resistance of Akt kinases to dephosphorylation through ATP-dependent conformational plasticity. Proc Natl Acad Sci U S A 108:E1120-1127.
12. Chen-Hwang MC, Chen HR, Elzinga M, Hwang YW. 2002. Dynamin is a minibrain kinase/dual specificity Yak 1-related kinase 1A substrate. J Biol Chem 277:17597-17604.
13. Chin LS, Nugent RD, Raynor MC, Vavalle JP, Li L. 2000. SNIP, a novel SNAP-25-interacting protein implicated in regulated exocytosis. J Biol Chem 275:1191-1200.
14. de Graaf K, Hekerman P, Spelten O, Herrmann A, Packman LC, Büssow K, Müller-Newen G, Becker W. 2004. Characterization of cyclin L2, a novel cyclin with an arginine/serine-rich domain: phosphorylation by DYRK1A and colocalization with splicing factors. J Biol Chem 279:4612-4624.
15. de Graaf K, Czajkowska H, Rottmann S, Packman LC, Lilischkis R, Lüscher B, Becker W. 2006. The protein kinase DYRK1A phosphorylates the splicing factor SF3b1/SAP155 at Thr434, a novel in vivo phosphorylation site. BMC Biochem 7:7-19.
16. Dowjat WK, Adayev T, Kuchna I, Nowicki K, Palminiello S, Hwang YW, Wegiel J. 2007. Trisomy-driven overexpression of DYRK1A kinase in the brain of subjects with Down syndrome. Neurosci Lett 413:77-81.
17. Dowjat K, Adayev T, Kaczmarski W, Wegiel J, Hwang YW. 2012. Gene dosage-dependent association of DYRK1A with the cytoskeleton in the brain and lymphocytes of Down syndrome patients. J Neuropathol Exp Neurol 71:1100-1112.
18. Funchal C, de Almeida LM, Oliveira Loureiro S, Vivian L, de Lima Pelaez P, Dall Bello Pessutto F, Rosa AM, Wajner M, Pessoa Pureur R. 2003. In vitro phosphorylation of cytoskeletal proteins from cerebral cortex of rats. Brain Res Protoc 11:111-118.
19. Guimera J, Casas C, Estivill X, Pritchard M. 1999. Human minibrain homologue (MNBH/DYRK1): characterization, alternative splicing, differential tissue expression, and overexpression in Down syndrome. Genomics 57:407-418.
20. Gwack Y, Sharma S, Nardone J, Tanasa B, Iuga A, Srikanth S, Okamura H, Bolton D, Feske S, Hogan PG, Rao A. 2006. A genome-wide Drosophila RNAi screen identifies DYRK-family kinases as regulators of NFAT. Nature 441:646-650.
21. Halligan BD, Ruotti V, Jin W, Laffoon S, Twigger SN, Dratz EA. 2004. ProMoST (Protein Modification Screening Tool): a web-based tool for mapping protein modifications on 2 dimensional gels. Nucleic Acids Res 32:W638-644.
22. Hämmerle B, Carnicero A, Elizalde C, Ceron J, Martínez S, Tejedor FJ. 2003. Expression patterns and subcellular localization of the Down syndrome candidate protein MNB/DYRK1A suggest a role in late neuronal differentiation. Eur J Neurosci 17:2277-2286.
23. Himpel S, Panzer P, Eirmbter K, Czajkowski H, Sayed M, Packman LC, Blundell T, Kentrup H, Grötzinger J, Joost H-G, Becker W. 2001. Identification of the autophosphorylation sites and characterization of their effects in the protein kinase DYRK1A. Biochem J 359:497-505.
24. Humphries KM, Deal MS, Taylor SS. 2005. Enhanced dephosphorylation of cAMP-dependent protein kinase by oxidation and thiol modification. J Biol Chem 280:2750-2758.
25. Jideama NM, Crawford BH, Hussain AKMA, Raynor RL. 2006. Dephosphorylation specificities of protein phosphatase for cardiac troponin I, troponin T, and sites within troponin T. Int J Biol Sci 2:1-9.
26. Kentrup H, Becker W, Heukelbach J, Wilmes A, Schurmann A, Huppertz C, Kainulainen H, Joost HG. 1996. Dyrk, a dual specificity protein kinase with unique structural features whose activity is dependent on tyrosine residues between subdomains VII and VIII. J Biol Chem 271:3488-3495.
27. Kida E, Walus M, Jarzabek K, Palminiello S, Albertini G, Rabe A, Hwang YW, Golabek AA. 2011. Form of dual-specificity tyrosine-(Y)-phosphorylation-regulated kinase 1A nonphosphorylated at tyrosine 145 and 147 is enriched in the nuclei of astroglial cells, adult hippocampal progenitors, and some cholinergic axon terminals. Neuroscience 195:112-127.
28. Kim EJ, Sung JY, Lee HJ, Rhim H, Hasegawa M, Iwatsubo T, Min do S, Kim J, Paik SR, Chung KC. 2006. Dyrk1A phosphorylates alpha-synuclein and enhances intracellular inclusion formation. J Biol Chem 281:33250-33257.
29. Kinoshita E, Kinoshita-Kikuta E. 2011. Improved Phos-tag SDS-PAGE under neutral pH conditions for advanced protein phosphorylation profiling. Proteomics 11:319-323.
30. Liu F, Liang Z, Wegiel J, Hwang YW, Iqbal K, Grundke-Iqbal I, Ramakrishna N, Gong CX. 2008. Over-expression of Mnb/Dyrk1A contributes to neurofibrillary degeneration in Down syndrome. FASEB J 22:3224-3233.
31. Liu T, Sims D, Baum B. 2009. Parallel RNAi screens across different cell lines identify generic and cell type-specific regulators of actin organization and cell morphology. Genome Biol 10:R26.
32. Mao J, Maye P, Kogerman P, Tejedor FJ, Toftgard R, Xie W, Wu G, Wu D. 2002. Regulation of Gli1 transcriptional activity in the nucleus by Dyrk1. J Biol Chem 277:35156-35161.
33. Martí E, Altafaj X, Dierssen M, de la Luna S, Fotaki V, Alvarez M, Perez-Riba M, Ferrer I, Estivill X. 2003. Dyrk1A expression pattern supports specific roles of this kinase in the adult central nervous system. Brain Res 964:250-263.
34. Martinez de Lagran M, Benavides-Piccione R, Ballesteros-Yañez I, Calvo M, Morales M, Fillat C, Defelipe J, Ramakers GJ, Dierssen M. 2012. Dyrk1A influences neuronal morphogenesis through regulation of cytoskeletal dynamics in mammalian cortical neurons. Cereb Cortex doi:10.1093/cercor/bhr362.
35. Mazur-Kolecka B, Golabek A, Kida E, Rabe A, Hwang Y-W, Adayev T, Wegiel J, Flory M, Kaczmarski W, Marchi E, Frackowiak J. 2012. The effect of Dyrk1A activity inhibition on development of neuronal progenitors isolated from Ts65Dn mice. J Neurosci Res 90:999-1010.
36. Murakami N, Xie W, Lu RC, Chen-Hwang MC, Wieraszko A, Hwang YW. 2006. Phosphorylation of amphiphysin I by minibrain kinase/dual-specificity tyrosine phosphorylation-regulated kinase, a kinase implicated in Down syndrome. J Biol Chem 281:23712-23724.
37. Murakami N, Bolton D, Hwang Y-W. 2009. Dyrk1A bind to multiple endocytic proteins required for clathrin coated vesicle formation. Biochemistry 48:9297-9305.
38. Nebl T, Pestonjamasp KN, Leszyk JD, Crowley JL, Oh SW, Luna EJ. 2002. Proteomic analysis of a detergent-resistant membrane skeleton from neutrophil plasma membranes. J Biol Chem 277:43399-43409.
39. Park J, Sung JY, Park J, Song WJ, Chang S, Chung KC. 2012. Dyrk1A negatively regulates the actin cytoskeleton through threonine phosphorylation of N-WASP. J Cell Sci 125:67-80.
40. Petrucci TC, Morrow JS. 1991. Actin and tubulin binding domains of synapsins Ia and Ib. Biochemistry 30:413-422.
41. Scales TME, Lin S, Kraus M, Goold RG, Gordon-Weeks PR. 2009. Nonprimed and DYRK1A-primed GSK3β-phosphorylation sites on MAP1B regulate microtubule dynamics in growing axons. J Cell Sci 122:2424-2435.
42. Shi J, Zhang T, Zhou C, Chohan MO, Gu X, Wegiel J, Zhou J, Hwang Y-W, Iqbal K, Grundke-Iqbal I, Gong C-X, Liu F. 2008. Increased dosage of Dyrk1A alters ASF-regulated alternative splicing of tau in Down syndrome. J Biol Chem 283:28660-28669.
43. Sitz JH, Baumgärtel K, Hämmerle B, Papadopoulos C, Hekerman P, Tejedor FJ, Becker W, Lutz B. 2008. The Down syndrome candidate dual-specificity tyrosine phosphorylation-regulated kinase 1A phosphorylates the neurodegeneration-related septin 4. Neuroscience 157:596-605.
44. Slepak TI, Salay LD, Lemmon VP, Bixby JL. 2012. Dyrk kinases regulate phosphorylation of doublecortin, cytoskeletal organization, and neuronal morphology. Cytoskeleton 69:514-527.
45. Song WJ, Chung SH, Kurnit DM. 1997. The murine Dyrk protein maps to chromosome 16, localizes to the nucleus, and can form multimers. Biochem Biophys Res Commun 231:640-644.
46. Tejedor FJ, Hämmerle B. 2011. MNB/DYRK1A: a multiple regulator of neuronal development. FEBS J 278:223-235.
47. Wegiel J, Kuchna I, Nowicki K, Frackowiak J, Dowjat K, Silverman WP, Reisberg B, DeLeon M, Wisniewski T, Adayev T, Chen-Hwang M-C, Hwang Y-W. 2004. Cell type- and brain structure-specific patterns of distribution of minibrain kinase in human brain. Brain Res 1010:69-80.
48. Wegiel J, Dowjat K, Kaczmarski W, Kuchna I, Nowicki K, Frackowiak J, Mazur-Kolecka B, Wegiel J, Silverman WP, Reisberg B, DeLeon M, Wisniewski T, Gong C-X, Liu F, Adayev T, Chen-Hwang M-C, Hwang Y-W. 2008. The role of overexpressed DYRK1A protein in the early onset of neurofibrillary degeneration in Down syndrome. Acta Neuropathol 116:391-407.
49. Wegiel J, Gong CX, Hwang YW. 2011a. The role of DYRK1A in neurodegenerative diseases. FEBS J 278:236-245.
50. Wegiel J, Kaczmarski W, Barua M, Kuchna I, Nowicki K, Wang KC, Wegiel J, Yang S, Frackowiak J, Mazur-Kolecka B, Silverman WP, Reisberg B, Monteiro I, de Leon M, Wisniewski T, Dalton A, Lai F, Hwang YW, Adayev T, Liu F, Iqbal K, Iqbal IG, Gong CX. 2011b. Link between DYRK1A overexpression and several-fold enhancement of neurofibrillary degeneration with 3-repeat tau protein in Down syndrome. J Neuropathol Exp Neurol 70:36-50.
51. Woods YL, Cohen P, Becker W, Jakes R, Goedert M, Wang X, Proud CG. 2001. The kinase DYRK phosphorylates protein-synthesis initiation factor elF2Bepsilon at Ser539 and the microtubule-associated protein tau at Thr212: potential role for DYRK as a glycogen synthase kinase 3-priming kinase. Biochem J 355:609-615.
52. Yang EJ, Ahn YS, Chung KC. 2001. Protein kinase Dyrk1 activates cAMP response element-binding protein during neuronal differentiation in hippocampal progenitor cells. J Biol Chem 276:39819-39824.